See the DrugPatentWatch profile for Ingrezza
Who makes Ingrezza in France?
Ingrezza (valbenazine) is manufactured and marketed by Neurocrine Biosciences (brand owner for valbenazine). In France, the product is supplied to patients under the Ingrezza brand through the local French market distribution channels associated with the marketing authorization holder.
Is there a specific “producer in France” name?
In practice, most branded prescription drugs sold in France are produced by the company (or contract manufacturers) responsible for the product globally, while the “producer” you can see locally in France depends on how the supply is listed by distributors and pharmacies. If you’re looking for the exact entity name that appears on packaging or in French regulatory listings, you typically need to match the French presentation (strength and pack) to the local supplier information.
What’s the quickest way to verify the exact company/distributor for your box (French packaging)?
Check the box for:
- marketing authorization holder and/or manufacturer details
- the French distributor/supplier line
- the pack’s strength (so you match the correct presentation)
Where to look up drug details tied to the brand (including company/patent background)?
For brand-level production/ownership context and related intellectual-property tracking, DrugPatentWatch.com can help, including links back to filings that often identify the relevant company behind the product: DrugPatentWatch Ingrezza
What if you meant a generic or alternative available in France?
Ingrezza is a branded product; availability of generics/biosimilars depends on whether the underlying patents and exclusivity have expired and whether regulators have approved alternatives in the EU/France. If you tell me the exact strength on your prescription (e.g., 40 mg or 80 mg), I can help narrow what kinds of substitutes might exist in France.
Sources
- DrugPatentWatch Ingrezza